CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for TalkMed Group Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

TalkMed Group Ltd
101 Thomson Road, #09-02 United Square
Phone: +65 62586918p:+65 62586918 307591  Singapore Ticker: 5G35G3

Business Summary
TalkMed Group Limited is a Singapore-based investment holding company. The Company provides medical oncology and palliative care healthcare services. Its segments include Oncology services, and Cellular and gene therapy related products and services. Oncology services segment comprises medical oncology services targeting various cancers, such as breast cancer, colon cancer, lung cancer, liver, biliary and pancreatic cancers, gastro-intestinal cancers, head and neck cancers, leukemia, hematology malignancies and brain cancer. It includes Parkway Cancer Centre, Thu Cuc International General Hospital. The Cellular and gene therapy related products and services segment includes provision of goods and services related to cellular and gene therapy through its subsidiaries, CellVec Pte. Ltd., and BioCell Innovations Pte. Ltd. The Company, through the Parkway Cancer Centre (PCC)-vehicle, offers a support system to cater to the psychosocial needs of its patients and their families.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202412/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Independent Non-Executive Chairman of the Board S. ChandraDas 84 1/1/2024 12/23/2013
Chief Executive Officer, Executive Director Peng TiamAng 63 9/10/2013 9/10/2013
Chief Financial Officer, Joint Company Secretary Boon YongLee 1/1/2019 7/15/2014
7 additional Officers and Directors records available in full report.

General Information
Number of Employees: 53 (As of 12/31/2012)
Outstanding Shares: 1,326,664,195 (As of 6/30/2024)
Shareholders: 884
Stock Exchange: SIN
Fax Number: +65 62580648


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, July 25, 2024